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Contribution of muscle relaxant to the haemodynamic course of high-dose fentanyl anaesthesia: a comparison of pancuronium, vecuronium and atracurium
To define the role of muscle relaxants in haemodynamic responses to high-dose (75 ~g.kg-l )fentanyl anaesthesia and to noxius stimuli associated with intubation and sternal spread during coronary artery byp~ts surgery, we compared haemodynamics between three groups of patients given either pancuronium (0.1 mg'kg -l, n = 11), vecuronium(O.O86 mg.kg -1, n = 11)or atracurium(0.43 mg'kg -1, n = 12). Additional doses of the relaxants were given to maintain a 90per cent neuromuscular block. Patients given pancuronium showed no increases in mean values of heart rate, arterial pressure or cardiac output during the induction of anaesthesia or after intubation, whereas a decrease in these variables was observed in the vecuroniurn group. The haemodynamics in the atracurium group were intermediate compared with the other two study groups. In spite of a decrease in coronary perfusion pressure, no patient given vecuronium developed myo-
Pancuronium has been widely used as a muscle relaxant during high-dose fentanyl anaesthesia for cardiac surgery. The rationale for this practice is that the vagolytic and sympathomimetic effects of pancuronium tend to antagonise the vagally mediated bradycardia resulting from fentanyl administration.l However, in some patients the heart rate accelerating effect of pancuronium may exceed the bradycardic effect of fentanyl. L2 Furthermore, pancuronium may also exaggerate circulatory responses to noxius stimuli 3 Since these properties of pancuronium may he harmful in patients with limited coronary vascular reserve, studies have been done to find out whether another neuromuscular blocking drug or drug combination might prove safer for these patients, z,4-6 Vecuronium and atracurium are new muscle relaxants without vagolytic and sympathomimetic effects (the absence of the latter effect in the case of atracurium is, however, not well documented). 7-H Like pancuronium, vecuronium does not release histamine. 12 Atracurium does cause release of histamine but in amounts less than those produced by metocurine or tubocurarine. ~3 Thus, vecuronium and atracurium should be potentially useful muscle relaxants for cardiac patients. In our previous study, pancuronium did not accelerate heart rate over the awake control level but only reversed the decrease in heart rate and cardiac output caused by fentanyl, whereas vecuronium further decreased these parameters. 6 In that study, succinylcholine was administered for intubation, and pancuronium or vecuronium was administered later. It is therefore possible that the haemodynamic effects of pancuronium and vecuronium were modified by the effect of succinylcholine on the autonomic nervous system 14 or by the delay of the administration of the nondepolarising relaxant. The present study differs from the previous one in that the nondepolarising relaxant was given before intubation and a patient group receiving atracurium was included.
Methods

Patients
Thirty-four patients scheduled for elective coronary artery bypass grafting (CABG) were studied. We excluded patients with significant valvular disease, those with critical narrowing of the left main coronary artery, and patients with ejection fraction < 0.40, as estimated by cineangiocardiography. The patients were randomly allocated to three groups, receiving either pancuronium, vecuronium or atracurium in a blind fashion. Beta-adrenergic blocking drugs and calcium entry blockers were continued up to the morning of the operation day. The patients gave their consent to the study, which had been approved by the Ethical Committee of the institute.
Anaesthesia
On the evening before operation the patients were given pentobarbitone 100-200mg and promethazine 25-50 mg orally. As premedication all patients received 0.2 mg.kg-t morphine and 0.006 mg.kg-i scopolamine intramuscularly. On arrival in the operating theatre, an intravenous infusion of Ringer's acetate solution was started and 0.1 mg. kg -I of diazepam was given intravenously in divided doses. During preparation of the monitoring, patients received 10ml.kg -I of Ringer's acetate and thereafter a constant infusion of 2 ml. kg-i.h -l. Radial arterial and triple-lumen pulmonap/ arterial catheters were inserted under local anaesthesia (one per cent lidocaine). During the preparation for anaesthesia the patients were given 35 per cent oxygen via a venturi mask.
Anaesthesia was induced with fentanyl at a rate of 7.5 ~tg.kg-l.min -1 to a total dose of 75 ~g.kg -~ . Three minutes after the start of the fentanyl infusion, a bolus dose of either pancuronium 0.1 mg. kg -l. vecuronium 0.086mg.kg -I or atracurium 0.43mg'kg -1 was given intravenously from a blinded syringe. Seven minutes after the administration of the muscle relaxant, the larynx and trachea were sprayed with four per cent lidocaine, 2 ml, and the trachea was intubated.
Ventilation was first assisted or controlled manually with 100 per cent oxygen using a nonrebreathing valve and, after intubation, controlled with a mixture of oxygen and air (F102 0.50) using the nonrebreathing circuit of a Servo 900 B ventilator. Respiratory rate was 12 breaths.min -~ and the tidal volume was adjusted to maintain PaCO2 at a normal level.
The degree of neuromuscular block was estimated using suprarnaximal ulnar nerve stimulation and quantitation of the evoked electromyographic response (NT-monitor, Organon). A neuromuscular block of at least 90 per cent was maintained by giving one-fifth of the initial dose of the relaxant when needed.
Study design and measurements
Systemic arterial pressure, pulmonary arterial pressure, central venous pressure and the V5 lead of the ECG were recorded throughout the study. More detailed haemodynamic measurements were made at the following times: (1) Five to ten minutes after the insertion of the vascular catheters. Haemodynamic measurements included heart rate (HR), systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), mean pulmonary arterial pressure (MPAP), mean pulmonary capillary wedge pressure (PCWP), mean central venous pressure (CVP) and cardiac output (CO). All pressures were measured with appropriate transducers zeroed to the midthoracic line and recorded with an ink-jet recorder. Mean pressures were transduced electronically and all pressures read at end-expiration. Cardiac output was measured with thermodilution using 0.9 per cent saline at room temperature and expressed as the mean of the values calculated from three well-formed curves. The following haemodynamic parameters were calculated using standard formulae: cardiac index (CI), stroke index (SI), systemic and pulmonary vascular resistances (SVR, PVR), rate-pressure product (RPP) and coronary perfusion pressure (CPP = DAP-PCWP).
Before opening the code of treatment, three investigators evaluated separately the ECG recordings for evidence of myocardial ischaemia. This was diagnosed when a new ST-segment depression ~> I mm was observed at a calibration of 10 mm/mV in lead Vs. The ST-segment was evaluated with respect to the PQjunction at a point 80 ms following the S-wave nadir. Mean values +-SD.
Statistical methods
Repeated measurements analysis of variance (BMDP program 8v) t5 was used to assess the significance of the changes over time and of the differences between the three groups. To supplement the analysis of variance, the t-test for paired data was applied to assess the significance of the changes from the control values within the groups and the t-test for unpaired data was used to compare changes between the groups. The Bonferroni allowance was used to correct for multiple pairwise testing. Fisher's exact test was applied to the frequency data to compute the exact two-tailed probabilities of observing the results due to chance, given the marginal totals.
Results
The three groups of patients were comparable with respect to preoperative characteristics (Tables I and  III) . Table II presents the arterial PCO2 values; the groups did not differ significantly with respect to this variable. Additional doses of the relaxants were given as follows: one dose of pancuronium, six patients; one-two doses of vecuronium, six patients; two-five doses of atracurium, 11 patients. Table HI and the Figure summarize the haemodynamic data. When the changes from the awake control values observed at various study periods were compared between the groups, the only significant difference between the pancuronium and atracurium groups was the greater PVR in the latter group after sternal spread. By contrast, comparison between the pancuronium and vecuronium groups revealed significant differences in HR, CI, MAP, RPP and CPP, the patients given vecuronium showing lower values in these variables than those receiving pancuronium. The significant differences in HR and CI were observed at the time of intubation, whereas those in MAP, RPP and CPP occurred mainly in the pre-and poststernotomy periods.
After sternal spread, the atracurium group had higher MAP, PVR and CPP than the vecuronium group. Even the pancuronium group showed no obvious haemodynamic response to endotracheal intubation, the intergroup difference in HR and CI resulting mainly from the decreased values in the vecuronium group. After sternal spread, the average MAP was significantly increased in the pancuronium and atracurium groups but reached only the control level in the vecuronium group. This increase in MAP was due to an elevation of SVR.
The incidences of notable haemodynamic changes are presented in Table IV . There were significant differences between the pancuronium and vecuronium groups in the incidence of marked bradycardia (HR < 45 beats.min -~) and in the incidence of HR exceeding the control value by 10 beats.rain-1. A decrease in systolic medal pressure necessitating treatment with ephendrine (< 80 mmHg) was observed in one patient and he had received pancuronium. Flushing was not seen in any of the patients.
Five patients showed significant (0.1-0.15 mV) ST-segment depression during the awake control stage, but these ECG findings remained unchanged during the later study periods. New electrocardiographic changes of myocardial ischaemia were noted in two patients receiving pancuronium and in two given atracurium. One patient of the pancuronium group and another of the atracurium group showed ST-segment depression after sternotomy. The former patient bad an increase in HR from the control value of 78 to 96 beats.rain -~ and the latter from 62 to 100 beats.min -1. In the other two patients, ST-segment depression occurred after the administration of the muscle relaxant. In the patient receiving pancuronium, HR was decreased and in the patient receiving atracurium, HR increased only slightly. However, both these patients experienced a decrease in CPP (P: from 55 to 40 mmHg; A: from 51 to 38 mmHg).
Discussion
In our pancuronium group, no changes were observed in the mean values of HR, MAP or any other -4000
. n FIGURE Changes from the awake control values of heart rate, rate-pressure product and coronary peffusion pressure induced by pancuronium (O), alracnrium (0) and vecuronium (x) during high-dose fentanyl anaesthesia. A = awake control, Ind = during induction of anaesthesia, preIt = before intuha/ion, It = after intubation, preS = before the start of surgery, S = after sternal spread. *p < 0.05; **p < 0.01; ***p < 0.001; significant change within the group, x, p < 0.05; • x, p < 0.01; significant difference between pancuronium and vecuronium groups. +, p < 0.05; significant difference between a~acurium and vccuronium groups. haemodynamic variable after the administration of the relaxant or after intubation. These findings are in agreement with those of others who have studied similar patients during high-dose fentanyl anaesthesia. 16-18 However, others have reported an increase in HR after the administration of pancuronium ~, 19.20 or significant haemodynamic responses to intubation. 19 In all these studies the dose of fentanyl was about the same and there were no great differences between the patient populations studied. However, in the studies in which an increase in HR was observed, either the beta-blockers were withheld from the night prior to surgery 19'2~ or diazepam was not given before fentanyl. 2 Diazepare in doses as small as used in the present study has been shown to convert the small increase in plasma catecholamines seen during induction of fentanyl-metocurine anaesthesia into a decrease and to significantly affect the haemodynamic course of the anaesthetic induction. 21
The post-relaxant haemodynamies of the present study are broadly comparable to those of our previous study in which pancuronium or vecuronium was administered after the patients had recovered from succinylcholine-induced neuromuscular block. 6 It is therefore probable that succinylcholine does not significantly modify haemodynamic responses to pancuronium or vecuronium during high-dose fentanyl anaesthesia preceded by intravenous diazepam. As in our pancuronium group, we found no significant changes in the mean haemodynamic values of our atracurium group after the administration of the relaxant and after intubation. Furthermore, the incidences of hypotension and tachycardia were not greater in the atracurium group than in the other study groups and flushing was not observed in any of the patients receiving atracurium. These haemodynamic findings are in agreement with those of Start et a1., 22 who gave a similar dose of atracurium during high-dose fentanyl anaesthesia. However, Skourtis el al. 23 reported a significant decrease in MAP and SVR after a bolus dose of 0.35 mg.kg -~ of atracurium during high-dose fentanyl anaesthesia although a dose of 0.3 mg'kg -I did not produce any haemodynamic changes. In addition, in another study, one of the 16 patients with coronary artery disease exhibited a typical circulatory histamine response after a bolus dose of 0.3 mg-kg-1 of atracurium during lorazepam-N20-fentanyl anaesthesia. 24 Almost all patients of our atracurium group required an additional dose of the relaxant before sternotomy. It is, however, uncertain whether the small increase in PVR observed in our patients at the time of sternotomy is due to histamine release. There is some evidence that it is the size of the bolus dose of atracurium and not the total dose that will determine the occurrence of haemodynamic changes, z3 Although we found no clinical signs of histamine release after a rapid injection of a dose of atracurium permitting intubation, it is probably wise to inject such doses slowly in order to avoid histamine-induced circulatory changes in occasional patients. 25 Perhaps the administration of the H1 antagonist promethazine on the evening before surgery may have influenced the haemodynamie response to atracurium in this study.
The differences in HR, CI and MAP between our vecuronium and pancuronium groups may be explained by the vagolytic and sympathomimetic effects of pancuronium which tended to counteract the depressing effect of fentanyl on these variables 6 In addition, our previous results suggest that vecuronium might have a moderate negative chrono-tropic effect. 6 However, no change in HR after vecuronium was observed in some other studies made in patients undergoing CABG under highdose fentany122'26 or halothane anaesthesia. 5 In the present study, the incidence of marked bradycardia (HR < 45 beats.min -1) was about the same as in our previous study; 6 however, sinus rhythm was maintained in all patients in these studies after vecuronium. An advantage of vecuronium over pancuronium and atracurium was the attenuation of blood pressure response to sternotomy.
The incidence of myocardial ischaemia before surgery was somewhat smaller in our patient groups (P 1/11, A 1/12; V 0/11) than that recently reported by Thomson and Putnins 2 in a patient group given pancuronium during the induction of high-dose fentanyl anaesthesia (3/12). Furthermore, in our patients ischaemia before surgery was not associated with an increase in HR and RPP, as was the case in Thomson's patients, but might rather be due to a decrease in CPP. However, no patient given vecuronium developed myocardial ischaemia despite a decrease in CPP during the induction of anaesthesia. In addition, no patient of the vecuronium group showed tachycardia or ST-segment depression during sternotomy. Larger patient groups are obviously needed to find out whether there is a real difference in the incidence of myocardial ischaemia between patients receiving various muscle relaxants.
The doses of the muscle relaxants used in the present study were calculated from the dose response curves obtained by Gramstad and Lilleaasen ~7 who used a cumulative dose regimen. Although a single bolus dose technique is obviously preferable for determining potency for relatively short-acting drugs like vecuronium and atracurium, 2s the potency ratios obtained with these two methods do not seem to differ significantly. 29 In summary, when administered during highdose fentanyl anaesthesia in patients under betaadrenergic blockade and pretreated with iv diazepare, pancuronium did not produce increases in heart rate, arterial pressure or cardiac output, whereas patients given vecuronium showed a decrease in these variables. The haemodynamie effects of atracurium were intermediate compared with the other two relaxants. In spite of a decrease in coronary perfusion pressure no patient given vecuronium developed myocardial ischaemia. An advantage of vecuronium over pancuronium and atracurium was an attenuation of the haemodynamic response to sternotomy.
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